Claudio Villota Arcos | Skin Aging | Research Excellence Award

Dr. Claudio Villota Arcos | Skin Aging | Research Excellence Award

Investigador | Universidad Bernardo O'Higgins | Chile 

Dr. Claudio Villota Arcos is a researcher specializing in cellular and molecular biology, with a strong interdisciplinary focus on cancer biology, mitochondrial genetics, virology, and nutrition-related molecular mechanisms. His research centers on the role of mitochondrial non-coding RNAs in cancer initiation, progression, and therapeutic targeting, alongside emerging interests in viral oncogenesis, metabolic regulation, and inflammation-linked diseases. Dr. Villota Arcos serves as an academic researcher at the School of Nutrition and Dietetics, Universidad Bernardo O’Higgins, where he integrates molecular biology with translational health research. His key contributions include pioneering discoveries on antisense mitochondrial non-coding RNAs as selective vulnerabilities in cancer cells, advancing novel molecular targets for cancer therapy, and influencing diagnostic and therapeutic research strategies. His impact vision emphasizes translating fundamental mitochondrial biology into clinically relevant innovations, strengthening precision oncology approaches, and bridging molecular science with public health and nutritional interventions for global disease prevention.

Citation Metrics (Scopus)

700

400

50

0

Citations
662

Documents
26

h-index
12

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
View Scopus profile View ORCID profile

Featured Publications


Expression of a family of noncoding mitochondrial RNAs

– Proceedings of the National Academy of Sciences,, 2009

Down-regulation of antisense mitochondrial non-coding

–. Journal of Biological Chemistry, 2014

Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Prof. Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Researcher | University of Athens | Greece

Panagiotis Halvatsiotis is an Assistant Professor of Medicine with specialization in endocrinology and metabolic research, focusing on diabetes, obesity, insulin resistance, and metabolic regulation across clinical and molecular contexts. His research explores skeletal muscle metabolism, protein synthesis, adipokine signaling, and the metabolic impact of nutritional and pharmacological interventions, alongside emerging interests in population-based metabolic risk and COVID-19–related metabolic outcomes. He holds key academic and clinical research roles within university medical settings and has collaborated extensively in multidisciplinary, international research teams. Dr. Halvatsiotis has made significant contributions through high-impact studies elucidating insulin action, amino acid kinetics, and metabolic dysregulation in type 2 diabetes, as well as influential systematic reviews informing dietary and public health policy. His work has generated widely cited evidence shaping clinical practice guidelines. His impact vision centers on translating metabolic research into scalable interventions that improve chronic disease management, inform evidence-based nutrition strategies, and advance global metabolic health innovation.

Citation Metrics (Google Scholar)

1500

1000

600

0

Citations
1455

Documents
17

h-index
28

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar

Featured Publications